<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03411733</url>
  </required_header>
  <id_info>
    <org_study_id>HPAV001</org_study_id>
    <nct_id>NCT03411733</nct_id>
  </id_info>
  <brief_title>Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris</brief_title>
  <official_title>Prevalence of Helicobacter Pylori in Patients With Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to investigate prevalence of H.Pylori infection among acne
      vulgaris patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study included patients with acne vulgaris and healthy control participants. The study
      recruited both sexes, all grades of acne, adolescents and young adults.

      All patients were subjected to complete history, general and skin examination Acne vlugaris
      Patients were classified into mild, moderate and severe according to the classification of
      American Academy of dermatology for acne vulgaris.

      Detection of H. pylori infection:

      Blood and stool samples were taken from each participant and was directly transferred to
      laboratory for detection of H. Pylori antigen and antibody.

      An enzyme-linked immune sorbent assay (ELISA) was used for quantitative assessment of IgG
      antibodies against H.Pylori in human serum.

      A monoclonal antibodies based enzyme-linked immunosorbent assay was used to detect H.Pylori
      specific antigen in stool samples.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">February 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>H.pylori infection</measure>
    <time_frame>one year</time_frame>
    <description>Prevalence of H.pylori infection among acne group and control group</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>acne vlugaris group</arm_group_label>
    <description>Included recruited patients with acne vulgaris Intervention: Blood and stool samples collection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Included healthy participants Intervention: Blood and stool samples collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood and stool samples collection</intervention_name>
    <description>Collection of blood and stool samples from each participants for H.pylori antigen/ antibody detection</description>
    <arm_group_label>acne vlugaris group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and stool samples were retained for a short period (few hours) till completion of
      laboratory analyses
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acne vulgaris and presented to Dermatology outpatient clinic, Sohag
        University hospital.

        Healthy volunteers.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acne vulgaris patients

          -  Healthy volunteers (control)

        Exclusion Criteria:

          -  Patients with a history of drug intake that affects H. Pylori such as proton-pump
             inhibitors, clarithromycin, tetracyclines, amoxicillin or metronidazole within
             previous two weeks were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ramadan Saleh, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sohag Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dermatology outpatient clinic, Sohag University Hospital</name>
      <address>
        <city>Sohag</city>
        <zip>82524</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Dina Ali</investigator_full_name>
    <investigator_title>Resident physician, Department of Dermatology, Sohag Educational Hospital</investigator_title>
  </responsible_party>
  <keyword>acne vlugaris</keyword>
  <keyword>prevalence</keyword>
  <keyword>Helicobacter Pylori</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>All available data shall be shared with other researchers upon their request after agreement of study director</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

